11-823603-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_020376.4(PNPLA2):c.757+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000939 in 1,134,754 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00059 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00099 ( 6 hom. )
Consequence
PNPLA2
NM_020376.4 intron
NM_020376.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.841
Publications
0 publications found
Genes affected
PNPLA2 (HGNC:30802): (patatin like phospholipase domain containing 2) This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy. [provided by RefSeq, Jul 2010]
PNPLA2 Gene-Disease associations (from GenCC):
- neutral lipid storage myopathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 11-823603-C-T is Benign according to our data. Variant chr11-823603-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261247.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000586 (85/144936) while in subpopulation SAS AF = 0.00147 (6/4074). AF 95% confidence interval is 0.000641. There are 0 homozygotes in GnomAd4. There are 51 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PNPLA2 | NM_020376.4 | c.757+16C>T | intron_variant | Intron 6 of 9 | ENST00000336615.9 | NP_065109.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PNPLA2 | ENST00000336615.9 | c.757+16C>T | intron_variant | Intron 6 of 9 | 1 | NM_020376.4 | ENSP00000337701.4 |
Frequencies
GnomAD3 genomes AF: 0.000594 AC: 86AN: 144784Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
86
AN:
144784
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000772 AC: 180AN: 233228 AF XY: 0.000858 show subpopulations
GnomAD2 exomes
AF:
AC:
180
AN:
233228
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000991 AC: 981AN: 989818Hom.: 6 Cov.: 34 AF XY: 0.00104 AC XY: 523AN XY: 505056 show subpopulations
GnomAD4 exome
AF:
AC:
981
AN:
989818
Hom.:
Cov.:
34
AF XY:
AC XY:
523
AN XY:
505056
show subpopulations
African (AFR)
AF:
AC:
5
AN:
23772
American (AMR)
AF:
AC:
10
AN:
40730
Ashkenazi Jewish (ASJ)
AF:
AC:
90
AN:
20082
East Asian (EAS)
AF:
AC:
1
AN:
29914
South Asian (SAS)
AF:
AC:
162
AN:
76334
European-Finnish (FIN)
AF:
AC:
5
AN:
40816
Middle Eastern (MID)
AF:
AC:
17
AN:
4548
European-Non Finnish (NFE)
AF:
AC:
645
AN:
712130
Other (OTH)
AF:
AC:
46
AN:
41492
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
49
98
146
195
244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000586 AC: 85AN: 144936Hom.: 0 Cov.: 32 AF XY: 0.000722 AC XY: 51AN XY: 70680 show subpopulations
GnomAD4 genome
AF:
AC:
85
AN:
144936
Hom.:
Cov.:
32
AF XY:
AC XY:
51
AN XY:
70680
show subpopulations
African (AFR)
AF:
AC:
9
AN:
40410
American (AMR)
AF:
AC:
9
AN:
14736
Ashkenazi Jewish (ASJ)
AF:
AC:
16
AN:
3340
East Asian (EAS)
AF:
AC:
1
AN:
4334
South Asian (SAS)
AF:
AC:
6
AN:
4074
European-Finnish (FIN)
AF:
AC:
0
AN:
9174
Middle Eastern (MID)
AF:
AC:
3
AN:
288
European-Non Finnish (NFE)
AF:
AC:
38
AN:
65658
Other (OTH)
AF:
AC:
3
AN:
2064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Neutral lipid storage myopathy Benign:1
Jan 17, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.